FDA recalls two products for potential of serious harmÂ
The Food and Drug Administration July 21 identified Class I recalls of two products due to the potential for serious injury or death. were recalled due to incomplete bioburden assessments and sterilization location transfer documentation. The recall involves removing devices from where they are used or sold. were recalled due to a risk of an inaccurate compliance measurement leading to improper tidal volume delivery in neonatal patients. The recall involves updating instructions for using devices.
Related News Articles
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
The Food and Drug Administration has identified a Class I recall of certain lots of BD esophagogastric balloon tamponade tubes due to the potential for serious…
Headline
The Food and Drug Administration has identified a Class I recall of Q’Apel Medical 072 Aspiration System after the company submitted three device event reports…
Headline
The Food and Drug Administration has identified a Class I recall of Becton, Dickinson and Company BD Alaris Systems Manager and BD Care Coordination Engine…
Headline
The Food and Drug Administration has identified a Class I recall of Medtronic Neurovascular 027 Compatible Pipeline Vantage Embolization Devices due to reports…
Headline
The Food and Drug Administration March 5 announced that Baxter Healthcare Corporation recalled its Spectrum infusion pumps due to the potential for missing…